Clinician In -Residence

As our Clinician In -Residence, you will be the medical voice across product, clinical operations, regulatory strategy, patient experience, and research as we bring breath -based cancer detection to the world.

About the Role

This is a cross -functional medical role, involving work across product, clinical operations, medical affairs, regulatory, patient experience, and research. Dognosis runs a multi -site prospective clinical study under ICH -GCP and Indian GCP compliance, and is preparing for commercial rollout. You will be embedded across both: shaping protocols and ensuring scientific rigor today, and helping build the medical foundation for a consumer screening product tomorrow.

What You'll Do

• Shape study protocols and clinical workflows alongside the Clinical & Founding Team.
  
• Shape the user experience and customer journey for our breath -based product(s) for MCED (multi -cancer early detection) and recurrence monitoring.
  
• Build and iterate on the counselling workflow for BreathEasy users on their screening results and serve as the medical point of contact for patient -facing interactions.
  
• Contribute to research publications and represent Dognosis at scientific conferences.
  

What You Need

• MBBS with registration to practice in India, and ideally in Karnataka.
  
• Strong communication skills. You can explain complex medical concepts in simple terms to customers and the general public, while retaining strong clinical confidence with clinicians.
  
• Genuine interest in product development. You want to shape how diagnostics reach people.
  
• Comfort in unstructured environments where you define your own priorities and work across functions.
  
• Interest in research and figuring out novel care pathways.
  

Nice to have

• Experience in clinical research, whether during training, residency, or independently.
  
• Experience in public -facing community (blog, social media, educational content).
  
• Experience in product development.
  

What You'll Get

• Potential co -authorship on research in top -tier journals. Dognosis has been published in the Journal of Clinical Oncology and presents frequently at ASCO, AACR, Cancer Research UK.
  
• Network and interactions with leading hospitals in India and the USA (Narayana Health, KMCRI, Tata Memorial, Harvard's Dana -Farber Cancer Institute) and globally renowned researchers.
  
• Competitive salary and matching perks at a company backed by Accel, Berkeley's The House Fund, and other leading global investors.
  
• Working with a high -touch interdisciplinary team spanning engineers, scientists, and working detection dogs. The office is never boring.
  
• Ownership over a novel product with potential for a paradigm -shift in oncology and how we detect and treat cancer.